INSURASALES

Tag: Healthcare Regulation

UnitedHealth Faces DOJ Scrutiny Over Medicare Advantage as Industry Faces AI and Market Shifts

UnitedHealth Group responds to DOJ investigations into Medicare Advantage amid broader insurance market changes including AI automation and pharmaceutical supply dynamics.

CMS Proposes Key Medicare Part B Pricing and Reporting Updates for 2026

CMS's 2026 proposed rules for Medicare Part B include major updates to average sales price calculations, Inflation Reduction Act compliance, ASP documentation, and Medicare inflation rebates affecting government pricing.

Illinois Metro-east Hospitals Prepare for Medicaid Funding Cuts and Capacity Shifts

Illinois metro-east hospitals brace for Medicaid funding cuts under new federal law, investing in outpatient care to offset losses. Medicaid work requirements and reduced reimbursements alter hospital financial outlook through 2026 and beyond.

CMS Launches Hospital Drug Acquisition Cost Survey Under Executive Order to Inform Medicare Payment Adjustments

CMS initiates survey collecting hospital outpatient drug acquisition costs to align Medicare payments with actual costs under the 2026 OPPS update, following a federal Executive Order to reduce prescription drug expenses.

Medical Debt Financing Firms Target Rural Hospitals Amid U.S. Healthcare Funding Cuts

Explore how medical debt financing companies support rural hospitals facing financial challenges amid Medicaid and ACA funding cuts, impacting uninsured patients and hospital revenue cycles.

Hospice Industry Faces Regulatory and Medicare Advantage Integration Challenges in 2025

Hospices confront rising operational costs, increased audits, and potential Medicare Advantage coverage changes in 2025, impacting hospice care delivery and financial sustainability.

UnitedHealth CEO Replacement Follows Medicare-Related Financial Challenges

UnitedHealth replaced CEO Andrew Witty after financial challenges related to Medicare coverage led to profit declines and withdrawn guidance, highlighting regulatory and cost pressures in the insurance market.

U.S. Pushes ‘Most Favored Nation’ Drug Pricing Policy Amid Legal and Industry Challenges

The U.S. administration advances a 'most favored nation' drug pricing policy to align Medicare prices with global low points, aiming to reduce prescription costs amid industry resistance and anticipated legal challenges.

Politico’s Sponsored Content Model Raises Ethical Concerns for U.S. Insurance and Policy

Politico’s use of sponsored content from health insurance and fossil fuel industries raises ethical questions about transparency and editorial independence, impacting U.S. Medicare Advantage and policy discourse.

Supreme Court Weighs ACA Preventive Services Coverage Amid Appointment Clause Challenge

Supreme Court examines constitutional challenge to ACA preventive services coverage focusing on the Appointments Clause and Secretary of HHS authority. Key implications for insurers and healthcare coverage.